CCK and migraine disorder: In this study, we found that inhibition of GSK-3β (e.g., by AR-A014418) largely diminished SANP-induced expression and production of CGRP, as well as other known migraine-related factors (e.g., SP, CCK, PEG2) in cultured cells.